Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells

AB Zaid, SK Almady, SM Awad, MG Elabd… - Current Research in …, 2024 - Elsevier
Background One of the prominent causes of chronic liver disease worldwide is the hepatitis
C virus (HCV). HCV believed that innate immunity contributes to a sustained virological …